Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials

被引：0
|
作者：
Mingnian Li [1 ]
Zhuoqi Ge [2 ]
Benqi Zhang [1 ]
Li Sun [2 ]
Zhongyuan Wang [2 ]
Tao Zou [3 ]
Qi Chen [1 ]
机构：
[1] Guizhou Medical University,College of Pharmacy
[2] Guizhou Provincial People’s Hospital,Department of Pharmacy
[3] Beijing Jishuitan Hospital Guizhou Hospital,Department of Pharmacy
来源：
Archives of Osteoporosis | / 19卷 / 1期
关键词：
D O I：
10.1007/s11657-024-01478-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
    Li, Mingnian
    Ge, Zhuoqi
    Zhang, Benqi
    Sun, Li
    Wang, Zhongyuan
    Zou, Tao
    Chen, Qi
    ARCHIVES OF OSTEOPOROSIS, 2024, 19 (01)
  • [2] Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials
    Kobayashi, Takaomi
    Morimoto, Tadatsugu
    Ito, Koji
    Mawatari, Masaaki
    Shimazaki, Takafumi
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (08) : 1377 - 1393
  • [3] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    P.D. Miller
    N. Pannacciulli
    J. Malouf-Sierra
    A. Singer
    E. Czerwiński
    H.G. Bone
    C. Wang
    S. Huang
    A. Chines
    W. Lems
    J.P. Brown
    Osteoporosis International, 2020, 31 : 181 - 191
  • [4] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Huang, S.
    Chines, A.
    Lems, W.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (01) : 181 - 191
  • [5] Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
    Chen, Liangshi
    Ji, Bomei
    Xia, Cong
    FRONTIERS IN ENDOCRINOLOGY, 2025, 16
  • [6] Efficacy and safety of denosumab and teriparatide versus oral bisphosphonates to treat postmenopausal osteoporosis: a systematic review and meta-analysis
    Yang, Jia
    Guo, Xiaobo
    Cui, Zhongning
    Guo, Huikang
    Dong, Jia-Nan
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [7] Comparison of Denosumab and Bisphosphonates in Patients With Osteoporosis: A Meta-Analysis of Randomized Controlled Trials
    Lyu, Houchen
    Jundi, Bakr
    Xu, Chang
    Tedeschi, Sara K.
    Yoshida, Kazuki
    Zhao, Sizheng
    Nigwekar, Sagar U.
    Leder, Benjamin Z.
    Solomon, Daniel H.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (05) : 1753 - 1765
  • [8] The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
    Zhu, Yilin
    Huang, Zhonglian
    Wang, Yan
    Xu, Weicai
    Chen, Hongjiang
    Xu, Jiankun
    Luo, Shaowei
    Zhang, Yuantao
    Zhao, Di
    Hu, Jun
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2020, 22 : 7 - 13
  • [9] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates
    Miller, Paul D.
    Pannacciulli, N.
    Malouf, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, Rachel B.
    Brown, J. P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
    Yuan, Chuanjian
    Liang, Yanchen
    Zhu, Kai
    Xie, Wenpeng
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2023, 18 (01)
12345